Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Thomas · SciRah

Researcher profile · Semantic Scholar

A. Thomas

Share profile

A. Thomas — researcher profile on SciRah

h-index: 34
Works: 135
Citations: 4,468

Most-cited papers

Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study.
T. Price, M. Peeters, T. W. Kim, Jin Li +8 more
2014The Lancet Oncology463 citations Open access
Semantic Scholar
Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study.
T. Iveson, R. Donehower, I. Davidenko, S. Tjulandin +12 more
2014The Lancet Oncology262 citations
Semantic Scholar
High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
A. Pearson, E. Smyth, I. Babina, M. T. Herrera-Abreu +23 more
2016Cancer Discovery250 citations Open access
Semantic Scholar
Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial
L. Howells, Chinenye O O Iwuji, G. Irving, S. Barber +11 more
2019Journal of NutriLife228 citations Open access
Semantic Scholar
A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors
J. Rodón, H. Tawbi, A. Thomas, R. Stoller +13 more
2014Clinical Cancer Research220 citations Open access
Semantic Scholar
Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery
Ian R. Powley, Meeta S. Patel, Gareth J. Miles, H. Pringle +7 more
2020British Journal of Cancer195 citations Open access
Semantic Scholar
Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy
M. James, Chinenye O O Iwuji, G. Irving, Ankur Karmokar +15 more
2015Cancer Letters173 citations Open access
Semantic Scholar
Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes
Constantinos Alexandrou, S. Al-Aqbi, Jennifer A. Higgins, William Boyle +12 more
2018Scientific Reports100 citations Open access
Semantic Scholar
Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial.
D. Fennell, A. King, S. Mohammed, A. Branson +11 more
2021The Lancet Respiratory Medicine93 citations
Semantic Scholar
Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer
M. Lawler, D. Alsina, R. Adams, A. Anderson +85 more
2017Gut80 citations Open access
Semantic Scholar
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study.
G. Folprecht, C. Pericay, M. Saunders, A. Thomas +14 more
2016Annals of Oncology79 citations Open access
Semantic Scholar
Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial
G. R. Irving, Chinenye O O Iwuji, B. Morgan, D. Berry +4 more
2015Trials68 citations Open access
Semantic Scholar
A randomised controlled trial of six weeks of home enteral nutrition versus standard care after oesophagectomy or total gastrectomy for cancer: report on a pilot and feasibility study
D. Bowrey, M. Baker, V. Halliday, A. Thomas +4 more
2015Trials66 citations Open access
Semantic Scholar
Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer.
T. Price, T. W. Kim, Jin Li, S. Cascinu +6 more
2016European Journal of Cancer65 citations Open access
Semantic Scholar
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.
N. Joharatnam-Hogan, F. Cafferty, R. Hubner, D. Swinson +40 more
2019The Lancet Gastroenterology and Hepatology60 citations Open access
Semantic Scholar
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
P. Corrie, A. Marshall, P. Nathan, P. Lorigan +101 more
2018Annals of Oncology59 citations Open access
Semantic Scholar
A Five-Gene Hedgehog Signature Developed as a Patient Preselection Tool for Hedgehog Inhibitor Therapy in Medulloblastoma
Y. Shou, D. Robinson, D. Amakye, K. Rose +17 more
2014Clinical Cancer Research54 citations Open access
Semantic Scholar
Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity
N. Myint, A. Verma, D. Fernández-García, P. Sarmah +14 more
2018Cell Death and Disease52 citations Open access
Semantic Scholar
Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma
M. Openshaw, Ali Abdulnabi Suwaidan, B. Ottolini, D. Fernández-García +5 more
2020British Journal of Cancer50 citations Open access
Semantic Scholar
Impact of Emergent Circulating Tumor DNA RAS Mutation in Panitumumab-Treated Chemoresistant Metastatic Colorectal Cancer
T. W. Kim, M. Peeters, A. Thomas, P. Gibbs +5 more
2018Clinical Cancer Research50 citations Open access
Semantic Scholar
Phase II multicenter proof of concept study of AZD4547 in FGFR amplified tumours.
E. Smyth, N. Turner, C. Peckitt, A. Pearson +16 more
201543 citations
Semantic Scholar
Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Treated with Panitumumab in the ASPECCT Study
M. Peeters, T. Price, M. Boedigheimer, T. W. Kim +6 more
2018Clinical Cancer Research40 citations Open access
Semantic Scholar
Patient and Family Caregivers’ Experiences of Living With a Jejunostomy Feeding Tube After Surgery for Esophagogastric Cancer
V. Halliday, M. Baker, A. Thomas, D. Bowrey
2015JPEN - Journal of Parenteral and Enteral Nutrition35 citations Open access
Semantic Scholar
The role of stromal fibroblasts in lung carcinogenesis: A target for chemoprevention?
J. Mahale, Gintare Smagurauskaite, K. Brown, A. Thomas +1 more
2016International Journal of Cancer33 citations Open access
Semantic Scholar
Figitumumab in patients with refractory metastatic colorectal cancer previously treated with standard therapies: a nonrandomized, open-label, phase II trial
C. Becerra, R. Salazar, R. García-Carbonero, A. Thomas +8 more
2014Cancer Chemotherapy and Pharmacology31 citations
Semantic Scholar
Translating Curcumin to the Clinic for Lung Cancer Prevention: Evaluation of the Preclinical Evidence for Its Utility in Primary, Secondary, and Tertiary Prevention Strategies
L. Howells, J. Mahale, S. Sale, L. McVeigh +3 more
2014Journal of Pharmacology and Experimental Therapeutics29 citations Open access
Semantic Scholar
Comet assay measures of DNA damage as biomarkers of irinotecan response in colorectal cancer in vitro and in vivo
J. Wood, Andrew J. Smith, K. Bowman, A. Thomas +1 more
2015Cancer Medicine27 citations Open access
Semantic Scholar
Frequency of S492R mutations in the epidermal growth factor receptor: analysis of plasma DNA from patients with metastatic colorectal cancer treated with panitumumab or cetuximab monotherapy
T. Price, A. Ang, M. Boedigheimer, T. W. Kim +7 more
2020Cancer Biology & Therapy25 citations Open access
Semantic Scholar
The TICONC (Ticagrelor-Oncology) Study
Joy R. Wright, M. Chauhan, C. Shah, A. Ring +3 more
2020JACC CardioOncology24 citations Open access
Semantic Scholar
A Systematic Review Assessing Clinical Utility of Curcumin with a Focus on Cancer Prevention.
L. Howells, Rushad Malhotra Mukhtyar, Despoina Theofanous, C. Pepper +3 more
2021Molecular Nutrition & Food Research21 citations Open access
Semantic Scholar
Targeting cancer stem-like cells using dietary-derived agents - Where are we now?
Sameena Khan, Ankur Karmokar, L. Howells, A. Thomas +3 more
2016Molecular Nutrition & Food Research21 citations
Semantic Scholar
O-0011FREQUENCY OF S492R MUTATIONS IN THE EPIDERMAL GROWTH FACTOR RECEPTOR: ANALYSIS OF PLASMA DNA FROM METASTATIC COLORECTAL CANCER PATIENTS TREATED WITH PANITUMUMAB OR CETUXIMAB MONOTHERAPY
K. Newhall, T. Price, M. Peeters, Tark Kim +12 more
201421 citations Open access
Semantic Scholar
Phase II study of AZD4547 in FGFR amplified tumours: Gastroesophageal cancer (GC) cohort pharmacodynamic and biomarker results.
E. Smyth, N. Turner, A. Pearson, C. Peckitt +16 more
201620 citations
Semantic Scholar
Prevalence and outcomes of patients (pts) with EGFR S492R ectodomain mutations in ASPECCT: Panitumumab (pmab) vs. cetuximab (cmab) in pts with chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer (mCRC).
T. Price, K. Newhall, M. Peeters, T. W. Kim +10 more
201518 citations
Semantic Scholar
Patients' experiences of an initial consultation in oncology: knowing and not knowing.
Lynn Furber, S. Bonas, G. Murtagh, A. Thomas
2015British Journal of Health Psychology18 citations
Semantic Scholar
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors.
C. Stavraka, A. Pouptsis, A. Synowiec, V. Angelis +18 more
2021Clinical colorectal cancer15 citations Open access
Semantic Scholar
Effects of Omegaven®, EPA, DHA and oxaliplatin on oesophageal adenocarcinoma cell lines growth, cytokine and cell signal biomarkers expression
A. Eltweri, L. Howells, A. Thomas, A. Dennison +1 more
2018Lipids in Health and Disease15 citations Open access
Semantic Scholar
Six weeks of home enteral nutrition versus standard care after esophagectomy or total gastrectomy for cancer: study protocol for a randomized controlled trial
D. Bowrey, M. Baker, V. Halliday, A. Thomas +2 more
2014Trials15 citations Open access
Semantic Scholar
The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring
M. Openshaw, C. Richards, D. Guttery, J. Shaw +1 more
2017Expert Review of Molecular Diagnostics13 citations
Semantic Scholar
The Effect of Supplementary Omegaven® on the Clinical Outcome of Patients With Advanced Esophagogastric Adenocarcinoma Receiving Palliative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy: A Phase II clinical trial
A. Eltweri, A. Thomas, W. Chung, B. Morgan +3 more
2019Anticancer Research12 citations Open access
Semantic Scholar
Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma
A. Thomas, P. Virdee, M. Eatock, S. Lord +9 more
2019European Journal of Cancer11 citations Open access
Semantic Scholar
New Paradigms to Assess Consequences of Long-Term, Low-Dose Curcumin Exposure in Lung Cancer Cells
Gintare Smagurauskaite, J. Mahale, K. Brown, A. Thomas +1 more
2020Molecules10 citations Open access
Semantic Scholar
Bemcentinib and pembrolizumab in patients with relapsed mesothelioma: MIST3, a phase IIa trial with cellular and molecular correlates of efficacy.
M. Krebs, A. Branson, S. Barber, C. Poile +13 more
2023Journal of Clinical Oncology7 citations Open access
Semantic Scholar
A phase II trial of abemaciclib in patients with p16ink4a negative, relapsed mesothelioma.
D. Fennell, A. King, S. Mohammed, A. Branson +15 more
20216 citations
Semantic Scholar
Ziv-aflibercept (Z) in combination with FOLFIRI for second-line treatment of patients with metastatic colorectal cancer (mCRC): Interim safety data from the global Aflibercept Safety and Quality-of-Life Program (ASQoP and AFEQT) in patients age 65 or older.
R. Bordonaro, A. Sobrero, Luca Frassineti, L. Ciuffreda +7 more
20156 citations
Semantic Scholar
Establishment of CORONET; COVID-19 Risk in Oncology Evaluation Tool to identify cancer patients at low versus high risk of severe complications of COVID-19 infection upon presentation to hospital
R. Lee, Cong Zhou, Oskar Wysocki, Rohan Shotton +42 more
2020medRxiv5 citations Open access
Semantic Scholar
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial
C. Forde, R. McMullan, M. Clarke, R. Wilson +11 more
2020Trials5 citations Open access
Semantic Scholar
P2.06-02 Mesothelioma Stratified Therapy (MiST): A Phase IIA Umbrella Trial for Accelerating the Development of Precision Medicines
D. Fennell, M. Hudka, L. Darlison, K. Lord +22 more
2019Journal of Thoracic Oncology5 citations Open access
Semantic Scholar
Evaluation of emergent circulating tumor (ct) DNA RAS mutations in patients with metastatic colorectal cancer (mCRC) treated with panitumumab (pmab) monotherapy from the ASPECCT study
T. W. Kim, T. Price, Marc Peeters, A. Thomas +5 more
20165 citations
Semantic Scholar
(LDE225) in Patients with Advanced Solid Tumors Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib A Phase I, Multicenter, Open-Label, First-in-Human,
J. Rodón, H. Tawbi, A. Thomas
20145 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Howells×12
Invite
L. Howells — researcher profile on SciRah
K. Brown×10
Invite
K. Brown — researcher profile on SciRah
T. Price×8
Invite
T. Price — researcher profile on SciRah
M. Peeters×7
Invite
M. Peeters — researcher profile on SciRah

×7

Invite

T. W. Kim — researcher profile on SciRah

Invite

P. Ruff — researcher profile on SciRah

Invite

T. Iveson — researcher profile on SciRah

Invite

Jin Li — researcher profile on SciRah

Invite

S. Cascinu — researcher profile on SciRah

S. Tjulandin×5

Invite

S. Tjulandin — researcher profile on SciRah

Invite

B. Morgan — researcher profile on SciRah

Invite

C. Richards — researcher profile on SciRah